medigraphic.com
SPANISH

Revista de Enfermedades Infecciosas en Pediatría

Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 74

<< Back Next >>

Rev Enfer Infec Pediatr 2005; 18.19 (74)

Ibuprofen vs. paracetamol in control of fever of infective origan in children under two years old

Lavalle VA, Saucedo RJ, Jiménez EI, Flores NG
Full text How to cite this article

Language: Spanish
References: 15
Page: 38-42
PDF size: 119.31 Kb.


Key words:

children, fever, ibuprofen, paracetamol.

ABSTRACT

Introduction: Ibuprofen is a non-steroid antinflamatory drug with good effect in adults. There is limited experience with children under 2 years old.
Objective: To compare the effect of ibuprofen against paracetamol in children under 2 years old.
Material and methods: It’s an experimental, non-blinded, prospective, longitudinal and comparative study in children less than 2 years old with fever. Group A received paracetamol and group B received ibuprofen, one dose 10mg/kg/day PO. We compared the temperatures of the children during 6 hours with interval of 30 minutes; we also compared bound ureic nitrogen, and creatinine at the beginning and the end of the same time.
Results: The initial temperatures for group A were 38.7±0.4 and for group B 38.7±0.3. The reduction of the fever was faster and lasted longer with ibuprofen. BUN and creatinine had no differences at the beginning and the end of study.
Conclusion: The Ibuprofen can be used in children under 2 years old for control of fever; its effect is faster and longer lasting than that of paracetamol.


REFERENCES

  1. Anónimo. Ácido acetilsalicílico y síndrome de Reye. Rev Cubana Farm 1998;32:140-2.

  2. Botting R. Antipyretic therapy. Front Biosci 2004;9:956-66.

  3. Taylor L, Abarca S, Henry B, Friedman L. Use of Neo-melubrina,a banned antipyretic drug, in San Diego, California: a survey of patients and providers. Wst J Med 2001;175:159-63.

  4. Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract, Suppl 2003;135:9-12.

  5. Kelley M, Walson P, Edge J, Cox S, Mortensen E. Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin. Pharmacol Ther 1992;52:181-189.

  6. Autret-Leca E, Breat G, Jonville A. Comparative efficacy and tolerance of ibuprofen syrup and paracetamol syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. Eur J Clin Pharmacol 1994;46:9-17.

  7. Lesko SM. The safety of ibuprofen suspension in children. Int J Clin Pract Suppl 2003;135:50-3.

  8. Van Esch A, Van Steensel-moll HA, Steyerberg EW. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med 1995;149: 632-637.

  9. Kelley M, Walson P, Hayes J, Edge J. Safety of paracetamol and ibuprofen in febrile children. Drug Invest 1993;6:48-56.

  10. Mclntyre J, Hull D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. Arch Dis Child 1996;74:164-167.

  11. Wilson J, Brown D, Kears G, Eichier V, Johnnson V, Bertrand K. Single dose, placebo controlled comparative study of ibuprofen and paracetamol antipyresis in Children. J Pediatr 1991;119:809-811.

  12. Kauffman R, Sawyer L, Scheinbaum M. Antipyretic efficacy of ibuprofen Vs paracetamol. Am J Dis Child 1992;146:622-625.

  13. Perrot DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: a metaanalysis. Arch Pediatr Adolesc Med 2004;158:521-6.

  14. Crocetti M, Moghbeli N, Serwint J. Fever phobia revisited: Have parental misconceptions about fever changed in 20 years? Pediatrics 2001;107:1241-6.

  15. Carson SM. Alternating acetaminophen and ibuprofen in the febrile child: examination of the evidence regarding efficacy and safety. Pediatr Nurs 2003;29:389-82.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Enfer Infec Pediatr. 2005;18.19